National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey

Preventive Medicine

Volumn 100, Issue , 2017, Pages 243-247

  Watson, Meg ^a   Benard, Vicki ^a   King, Jessica ^a   Crawford, Anatasha ^a   Saraiya, Mona ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cancer screening; Cervical cancer; Cytology; HPV DNA test; Pap test

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; BLACK PERSON; CANCER SCREENING; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH INSURANCE; HISPANIC; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; IMMIGRANT; MIDDLE AGED; PAPANICOLAOU TEST; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; YOUNG ADULT; EARLY CANCER DIAGNOSIS; HEALTH SURVEY; MASS SCREENING; PAPILLOMAVIRUS INFECTION; STATISTICS AND NUMERICAL DATA; UTERINE CERVIX TUMOR;

ADULT; EARLY DETECTION OF CANCER; FEMALE; HEALTH SURVEYS; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 85019420801     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2017.05.004     Document Type: Article

References (22)

1. Committee on Practice Bulletins–Gynecology, Practice bulletin no. 168: cervical cancer screening and prevention. Obstet. Gynecol. 128:4 (2016), e111–e130.
2. Benard, V.B., Thomas, C.C., King, J., Massetti, G.M., Doria-Rose, V.P., Saraiya, M., et al. Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007–2012. MMWR Morb. Mortal. Wkly Rep. 63:44 (2014), 1004–1009.
3. Centers for Disease Control and Prevention, Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 56:rr02 (2007), 1–24.
4. Centers for Disease Control and Prevention, Cervical Cancer Screening Guidelines for Average-risk Women. Accessed on March 4 2016; Available from: http://www.cdc.gov/cancer/cervical/pdf/guidelines.pdf, 2013.
5. Chao, C., Silverberg, M.J., Becerra, T.A., Corley, D.A., Jensen, C.D., Chen, Q., et al. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system. Am. J. Obstet. Gynecol., 216(2), 2017 (151 e1-151 e9).
6. El-Zein, M., Richardson, L., Franco, E.L., Cervical cancer screening of HPV vaccinated populations: cytology, molecular testing, both or none. J. Clin. Virol. 76:Suppl. 1 (2016), S62–S68.
7. Healthy People 2020 [Internet], Washington, DC: U.S. Department of Health and Human Services. Office of Disease Prevention and Health Promotion, 2016 [cited August 4, 2016]. Available from http://www.healthypeople.gov/2020/topics-objectives/topic/cancer/objectives.
8. Huh, W.K., Ault, K.A., Chelmow, D., Davey, D.D., Goulart, R.A., Garcia, F.A., et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol. Oncol. 136:2 (2015), 178–182.
9. Kulasingam, S.L., Pagliusi, S., Myers, E., Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. Vaccine 25:48 (2007), 8110–8113.
10. Lowe, A., Saraiya, M., Joseph, R., Development of standardized questions to monitor cervical cancer screening and treatment in population-based surveys. International Papillomavirus Conference; 2015 September 17–21, 2015; Lisbon, Portugal, 2015.
11. Malagon, T., Drolet, M., Boily, M.C., Laprise, J.F., Brisson, M., Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination era. Cancer Epidemiol. Biomark. Prev. 24:1 (2015), 276–285.
12. National Center for Health Statistics, Centers for Disease Control and Prevention, National Health Interview Survey, 2015. Public-use Data File and Documentation. Accessed on November 30 2016; Available from: http://www.cdc.gov/nchs/nhis/quest_data_related_1997_forward.htm, 2016.
13. National Center for Health Statistics, Centers for Disease Control and Prevention, Survey Description, National Health Interview Survey, 2015. Accessed on November 30 2016; Available from: http://www.cdc.gov/nchs/nhis/quest_data_related_1997_forward.htm, 2016.
14. Rauscher, G.H., Johnson, T.P., Cho, Y.I., Walk, J.A., Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol. Biomark. Prev. 17:4 (2008), 748–757.
15. Rodriguez, A.C., Solomon, D., Herrero, R., Hildesheim, A., Gonzalez, P., Wacholder, S., et al. Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment. Am. J. Epidemiol. 178:5 (2013), 752–760.
16. Ryerson, A.B., Eheman, C.R., Altekruse, S.F., Ward, J.W., Jemal, A., Sherman, R.L., et al. Annual Report to the Nation on the Status of Cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer 122:9 (2016), 1312–1337.
17. Sabatino, S.A., White, M.C., Thompson, T.D., Klabunde, C.N., Cancer screening test use - United States, 2013. MMWR Morb. Mortal. Wkly Rep. 64:17 (2015), 464–468.
18. Saraiya, M., Steben, M., Watson, M., Markowitz, L., Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians. Prev. Med. 57:5 (2013), 426–433.
19. Tangka, F.K., Howard, D.H., Royalty, J., Dalzell, L.P., Miller, J., O'Hara, B.J., et al. Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997–2012. Cancer Causes Control 26:5 (2015), 671–686.
20. Tsui, J., Saraiya, M., Thompson, T., Dey, A., Richardson, L., Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J. Women's Health 16:10 (2007), 1447–1457.
21. U.S. Food and Drug Administration, FDA Approves First Human Papillomavirus Test for Primary Cervical Cancer Screening. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394773.htm, 2014.
22. White, A., Thompson, T.D., White, M.C., Sabatino, S.A., de Moor, J., Doria-Rose, P.V., et al. Cancer screening test use - United States, 2015. MMWR Morb. Mortal. Wkly Rep. 66:8 (2017), 201–206.